Here is the link to the study. Click through on that page for the full text in PDF format.

Nardelli, et al. “Crying wolf in time of Corona: the strange case of ivermectin and hydroxychloroquine. Is the fear of failure withholding potential life-saving treatment from clinical use?”
DOI: 10.22514/sv.2021.043
Online publish date: 11 March 2021

The study analyzed 7 Randomized Controlled Trials (RCTs) and found that use of ivermectin reduces risk of death from Covid-19 by 81% as compared to controls.

Each study on its own, and the set of studies combined, found that ivermectin was effective against Covid-19.

“A total of 1323 patients were randomized in 7 RCTs per-formed in 6 countries. Four trials were multicentric. Iver-mectin treatment resulted in a lower mortality when compared to placebo: 14/703 (2%) vs 57/620 (9%),P<0.01, odds ratio 0.19 (0.10, 0.34).”

The p-value for the meta-analysis was less than 0.01, which is clearly statistically significant. And the odds ratio means that Ivermectin reduced mortality by 81%, reducing risk of death from 1.00 for controls to 19% by comparison.

RCTs are the so-called gold standard for studies, and this is a meta-analysis which combines several RCTs. These results are far better than any set of studies on Remdesivir, an approved and widely used (to the tune of 3 billion dollars) medication. And yet ivermectin is still rejected by medical authorities and government, costing untold suffering and a massive death toll, most of which could be avoided by prompt use of ivermectin and use of Vitamin D as a prophylaxis and an adjunct treatment.

Ronald L Conte Jr
“an author, not a doctor”